Conference Coverage
Videos
NewsNetwork
OncLive® TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community

Tune in to our upcoming broadcast to learn about the latest advances in chronic lymphocytic leukmia and small lymphocytic lymphoma. Register today!

 

SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology®
Neoadjuvant HER2+
More >>
Related Articles
FDA Grants Durvalumab Plus Tremelimumab Orphan Drug Status in HCC
Novel Agents Generate Excitement in Advanced HCC, Cholangiocarcinoma
Questions Remain in Localized Pancreatic Cancer as More Treatment Modalities Emerge
Related Videos
Dr. Choti on Future Treatment of Patients With Stage IV Pancreatic Cancer
Dr. Ribeiro on Criteria for Determining Borderline Resectability in Pancreatic Cancer
Dr. Ferraro on the Use of Molecular Profiling in Pancreatic Cancer
OncologyLive > Vol. 20/No. 21 >

Rising Incidence of Fatty Liver Disease Holds Implications for Trends in HCC

Danielle Ternyila
Published: Tuesday, Nov 12, 2019
Katherine A. McGlynn, PhD, MPH, senior investigator in the Division of Cancer Epidemiology and Genetics at the National Cancer Institute

Katherine A. McGlynn, PhD, MPH

Nonalcoholic fatty liver disease (NAFLD), a risk factor linked to the development of hepatocellular carcinoma (HCC) and increased mortality, is growing in clinical significance, according to Katherine A. McGlynn, PhD, MPH.
... to read the full story
To Read the Full Story
REGISTER
LOG IN

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
 
x